Nova One Advisor
Hyperpigmentation Disorder Treatment Market | USD 11.57 Billion by 2034

Hyperpigmentation Disorder Treatment Market (Treatment Type: Cosmeceuticals, Laser Therapy, Chemical Peels, Microdermabrasion, Phototherapy, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2034

Status: Published Category: Healthcare Insight Code: 7714 Format: PDF / PPT / Excel

Hyperpigmentation Disorder Treatment Market Size and Growth

The global hyperpigmentation disorder treatment market size is calculated at USD 5.51 billion in 2025 and is forecasted to reach around USD 11.57 billion by 2034, accelerating at a CAGR of 8.6% from 2025 to 2034. The demand for non-invasive treatments like creams, serums, and laser therapies has increased, driving the global hyperpigmentation disorder treatment market. The growing concern about skin aesthetics fuels market growth.

Hyperpigmentation Disorder Treatment Market Size 2024 To 2034

Market Overview

The hyperpigmentation disorder treatment market is significantly growing, driven by increased awareness of hyperpigmentation prevalence, large patient pool, and availability of advanced healthcare technologies. Hyperpigmentation disorder treatments such as laser treatments, skin grafting, microdermabrasion, topical creams, serums, and chemical peels are trending in the market. Novel technology developments like AI-driven skin analysis and personalized skin care solutions drive innovation same non-invasive treatment options. Technological advancements enable the improvement of safety, comfort, efficiency, and outcomes. Furthermore, regulatory and pharmaceutical investments in the research and development sector allow access to more advanced and cost-effective treatment solutions.

The demand for non-invasive treatment, particularly laser-based and topical products for hyperpigmentation, has taken place, boosting significant market growth areas. Non-invasive treatments reduce downtimes and risk of complications. These procedures are more cost-effective, making them ideal for hyperpigmentation disorder treatments. Consumer preference for safer alternatives given the shift to non-invasive procedures. People are becoming aware of skin health, which drives demand for non-invasive treatments. Advancements in laser therapies, light-based therapies, chemical pills, microdermabrasion, topical creams, and serums are trending in the market. the growth in the adoption of at-home treatments, expected to witness further developments in hyperpigmentation disorder treatments.

  • Prevalence of skin disorders: the skin disorder prevalence such as melasma, age spots, and post-inflammatory hyperpigmentation has increased, driving demand for effective treatment solutions. 
  • Increase awareness: global awareness of skin health and the importance of addressing hyperpigmentation contributes to the demand for effective and minimally invasive hyperpigmentation disorder treatments. 
  • Disposable income: the increased access to disposable income is allowing spending on dermatological treatments. 
  • Demand for natural and sustainable products: consumers are seeking natural ingredients and sustainable products for their skin health, driving a significant impact on the development of eco-friendly hyperpigmentation disorder treatment solutions. 
  • Technological advancements: development of novel technologies like personalized skin care solutions an integration of AI driving innovations and developments of advanced treatment solutions. 

Demand for anti-aging treatment creates opportunities for the hyperpigmentation disorder treatment market to grow
The demand for anti-aging treatments has increased, driven by growing awareness of age-related skin issues and skincare. People are being more concerned about the reference full stop. The increased availability of non-invasive treatments, including topical creams, serums, and laser therapies, is contributing to the demand for anti-aging treatment solutions. The rising awareness and prevalence of hypopigmentation disorders are seeking dermatological treatments. The increased disposable income further allows spending on skin health and appearance. Furthermore, technological advances are ensuring access to aesthetic treatments, having a significant influence on skin appearance-conscious people. The demand for personalized skin care solutions is further contributing to innovations and advancements in technologies.

High Cost of Treatments to Hamper Market Growth

The high cost associated with hyperpigmentation disorder treatments is the major restraint on the market growth. Advanced treatment solutions such as laser therapies, chemical pills, and microdermabrasis are expensive treatment solutions. The devices further contribute to the high cost. Additionally, hyperpigmentation treatment requires multiple sessions, leading to a high-cost burden for patients. The high cost associated with these treatments reduces demand and limits the adoption rate.

Report Scope of Hyperpigmentation Disorder Treatment Market

Report Coverage Details
Market Size in 2025 USD 5.51 Billion
Market Size by 2034 USD 11.57 Billion
Growth Rate From 2025 to 2034 CAGR of 8.6%
Base Year 2024
Forecast Period 2025-2034
Segments Covered Disease Indication, Treatment Type, End-user, Regional
Market Analysis (Terms Used) Value (US$ Million/Billion) or (Volume/Units)
Regional scope North America; Europe; Asia Pacific; Central and South America; the Middle East and Africa
Key Companies Profiled Vivier Pharma, Obagi Cosmeceuticals LLC, RXi Pharmaceuticals Corporation, EpiPharm AG, Pierre Fabre, SkinCeuticals, Galderma S.A., ALLERGAN, Bayer AG., ABBY SKIN CLINIC, The Marbella Vein & Beauty Clinic

Segment insights

Hyperpigmentation Disorder Treatment Market By Disease Indication

The melasma segment generated the largest market share in 2024. The segment growth is attributed to the increased prevalence of melasma, especially among women and individuals with darker skin types. The availability of various treatment options for melasma, including topical medical chemical pills and laser treatments for the chemical pills and laser treatments contributes to segment expansion. The segment is expected to witness steady growth due to increased innovation of combination therapies.

The post-inflammatory hyperpigmentation (PIH) segment is the second largest segment leading the market due to various factors like increasing incidence of skin conditions, growing awareness about post-inflammatory hyperpigmentation treatment options, the importance of skin health, and developments of novel technologies and treatment options.

Hyperpigmentation Disorder Treatment Market By Treatment Type

The Laser Therapy segment dominated the market in 2024. Laser therapy provides a broad range of treatment options for various skin conditions, including hyperpigmentation. Advancement in laser technology Advancement in laser technology has improved its safety and efficiency. The high demand for minimally invasive procedures contributes significantly to the growth.

The phototherapy segment is projected to witness significant growth in the forecast period, driven by the high effectiveness of phototherapy devices such as medical lasers in treating hyperpigmentation. The demand for non-invasive treatment solutions contributes to the high adoption of phototherapy for hyperpigmentation.

Hyperpigmentation Disorder Treatment Market By End-user

The hospitals segment generated the biggest market share in 2024 with increased patient flow and demand for personalized treatment solutions. Hospitals are highly adopting edge technologies like laser therapy and phototherapy, contributing to improving patient experiences and health outcomes.

Hyperpigmentation Disorder Treatment Market By Regional Insights

High Patient Pool & Technologies: Asian Market to Sustain the Dominance

Asia Pacific dominated the global hyperpigmentation disorder treatment market in 2024. Asia Pacific has the largest patient pool, driven by the increased prevalence of hyperpigmentation disorders and high population. Hyperpigmentation disorder prevalence is high among the elderly population. Growing awareness about skin health is driving demand for advanced treatment solutions. Additionally, the availability of advanced technologies, new treatments and devices for hyperpigmentation, and disposable income enables the adoption of hyperpigmentation disorder treatment solutions.

Countries like Japan, China, Thailand, and India play a vital role in market expansion. Japan generated the largest market share due to the increased prevalence of hyperpigmentation disorders in the aging population and awareness about skin health. On the other hand, India is projected to witness significant growth in the forecast period, driven by increased patient food and demand for affordable hyperpigmentation treatment solutions. Additionally, pharmaceutical companies are exploring advances, to boost the treatment areas in India.

  • For instance, in February 2025, Alkem Laboratories Ltd. introduced its Kojiglo serum in India for facial hyperpigmentation.

  • In January 2025, Asaya, a skincare brand dedicated to catering to melanated skin, unveiled the MelaMe, a pioneering technology aimed at solving hyperpigmentation in Indian skin tones.

Rapid Adoption of Technology: North America to Boom Rapidly

North America accounted to witness significant forecast growth. Factors like the well-established healthcare industry, high adoption of noble technologies, and awareness of skin health contribute highly to market expansion in North America. North America witnessed a high prevalence of vitiligo. The presence of key vendors and the availability of advanced treatment such as laser therapy and phototherapy, boost hyperpigmentation disorder management.

The United States is leading the regional market due to high vitiligo prevalence and growing awareness about skin health. The strong presence of market players, availability of disposable income, and high demand for aesthetic treatments contribute to the growth. additionally, the high adoption of minimally invasive procedures in established healthcare infrastructure plays a favorable role.

Some of The Prominent Players In The Hyperpigmentation Disorder Treatment Market include:

Segments Covered in the Report

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2034. For this study, Nova one advisor, Inc. has segmented the Hyperpigmentation Disorder Treatment Market

By Disease Indication

  • Melasma
  • Post-inflammatory Hyperpigmentation
  • Solar Lentigines
  • Others

By Treatment Type

  • Topical Drugs
  • Laser Therapy
  • Chemical Peels
  • Microdermabrasion
  • Phototherapy
  • Others

By End-user

  • Hospitals
  • Aesthetic Clinics & Dermatology Centers
  • Others

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America 
  • Middle East & Africa
  • Insight Code: 7714
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: March 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034
FAQ's

The global hyperpigmentation disorder treatment market size is calculated at USD 5.51 billion in 2025 and is forecasted to reach around USD 11.57 billion by 2034, accelerating at a CAGR of 8.6% from 2025 to 2034.

The global medical imaging reagents market is poised to grow at a CAGR of 8.6% from 2025 to 2034.

The major players operating in the medical imaging reagents market are Bracco Spa, Lantheus Holdings, Inc, General Electric Company, Siemens AG, Bayer AG, CMC Contrast AB, Thermo Fisher Scientific Inc, Merck & Co., Inc, Shimadzu Corporation, Koninklijke Philips N.V.